Niño de 3 meses con anemia hemolítica no autoinmune. Article in Anales de Pediatría 55(3)– · December with 6 Reads. Article in Anales de Pediatría 71(3) · September with 56 Reads Anemia hemolítica autoinmune con prueba de antiglobulina positiva a. de Medicina Interna de una institución pediátrica de alto nivel de complejidad. El paciente consultó por un cuadro de anemia hemolítica autoinmune.

Author: Grosar Shakara
Country: Croatia
Language: English (Spanish)
Genre: Health and Food
Published (Last): 14 September 2007
Pages: 275
PDF File Size: 4.79 Mb
ePub File Size: 1.66 Mb
ISBN: 426-4-52663-255-5
Downloads: 36753
Price: Free* [*Free Regsitration Required]
Uploader: Mazahn

Anesthetic management of a pregnant woman with hemoliticw hemolytic anemia for an emergency cesarean section. Arthritis Rheum, 56pp. Author information Article notes Copyright and License information Disclaimer. Sustained response to low-dose rituximab in idiopathic autoimmune hemolytic anemia.

Anemia hemolitica 2013 pdf pediatria

Second-line therapy Once hemoltiica decision for a second-line treatment has been taken, there are several options, although splenectomy and rituximab are the only second-line treatments with a proven short-term efficacy. Patients with red cell autoantibodies: Arch Dis Child Fetal Neonatal ; In particular, the patient and the extremity chosen for infusion should be kept warm, and the use of an in-line blood warmer is recommended.

Anemia hemolitica autoinmune malalties minoritaries. Current usage of intravenous immune globulin and the rationale behind it: Prophylaxis and treatment of hepatitis B in immunocompromised patients. Successful outcomes with rituximab therapy for refractory childhood systemic lupus erythematosus.

We evaluated 17 patients younger than 15 years old admitted from to were evaluated.


Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias.

Heterogeneity of G6PD deficiency prevalence in Mozambique: Successful treatment of complement mediated refractory haemolysis associated with cold and warm autoantibodies using eculizumab abstract. A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory autoimmune thrombocytopenia. A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia.

Passweg JR, Rabusin M. Thirteen patients had severe anemia and needed blood transfusions. Cases J, 2pp. Successful treatment with rituximab and mycophenolate mofetil of refractory autoimmune hemolytic anemia post-hematopoietic stem cell transplant for dyskeratosis congenita due to TINF2 mutation.

A multi-center retrospective study of rituximab use in the treatment of relapsed or resistant warm hemolytic anemia.

Jornal de Pediatria

This study was carried out to identify the clinical, immunological and outcome characteristics of autoimmune hemolytic anemia patients treated at the HC-UFMG Pediatric Hematology Unit and the Hemocentro de Belo Horizonte. Rituximab for primary chronic cold agglutinin disease: However, no controlled clinical trials have yet been performed that can guide the choice of treatment. Alberto Zanella and Wilma Barcellini. Mycophenolate mofetil as a treatment for autoimmune haemolytic anaemia in patients with systemic lupus erythematosus and antiphospholipid syndrome.

How I manage cold agglutinin disease.

Treatment of autoimmune hemolytic anemia. Haematopoietic SCT in pediatrua autoimmune diseases: Deficiencia de glucosa 6-fosfato deshidrogenasa: Clinical analysis of cases Coombs test positive autoimmune haemolytic anemia. Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia. The diagnosis is usually simple, based on the presence of hemolytic anemia and serological evidence of anti-erythrocyte antibodies, detectable by the direct antiglobulin test DAT.


Maitland R, Valverde K. Autoimmune hemolytic anemia with both cold and warm autoantibodies.

Artigo Original

Clinical, laboratory, and outcome data were obtained from patient records. Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia. B hemolitkca depletion therapy in children with refractory systemic lupus erythematosus.

Efficacy of danazol in hematologic disorders. Pediatrics Country of publisher: Patients with AIHA may often require red blood cell RBC transfusion to maintain clinically acceptable hemoglobin values, at least until specific treatments become effective. Consenso para le enfermedad de Gaucher.

Acosta A, Valverde, K. Semin Oncol, 27pp. Therefore, properly designed clinical trials evaluating rituximab as salvage- and first-line-therapy for the treatment of AIHA and cold agglutinin disease are clearly warranted.

Mechanism of hemolysis and response to corticosteroids. Support Center Support Center. Int Immunopharmacol, 9pp.

For the former two conditions, the use of mono-specific antisera against IgA and low ionic strength solutions or cold washings can overcome the DAT negativity. An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries.

Underlying diseases were identified in four patients:

Subscribe US Now